T. Wakita et al., Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system, J MED VIROL, 62(3), 2000, pp. 308-317
A line of hepatitis C virus (HCV) transgenic mice was established previousl
y that was mediated by Cre/loxP system using HCV cDNA, including core, E1,
E2 and NS2 genes. Intravenous infection of a recombinant adenovirus that ex
presses Cre DNA recombinase (AxCANCre) induced HCV structural protein expre
ssion in the liver of transgenic mice. HCV core protein production and tran
sgene recombination in the mouse liver were serially evaluated after AxCANC
re infusion. Core proteins were expressed efficiently and transgene was alm
ost completely recombined in the liver of mice after 3 days and then the le
vels of both core protein production and transgene recombination decreased
continuously for 28 days. However, 30.6% of the trans gene recombination re
mained at 28 days and only 2.7% of core production remained at 28 days afte
r infection. Compared with non-transgenic controls, the serum alanine amino
transferase levels in transgenic mice were significantly higher 10, 14, and
21 days after adenovirus infection. Histological scoring also indicated se
vere pathological changes in the liver of transgenic mice after adenovirus
infection. AxCANCre infusion increased CD8(+) lymphocyte infiltration into
the liver of transgenic mice compared with that of non-transgenic controls,
furthermore, cytotoxic T lymphocytes (CTLs) isolated from transgenic mice
during liver injury were specific for the HCV proteins. These results sugge
st that HCV structural proteins expressed in the liver of transgenic mice e
nhanced liver injury. HCV-specific CTLs may be to enhance hepatitis. Thus,
the present HCV transgenic mouse model provides a useful model of liver inj
ury due to HCV, and the host immune response may play a pivotal role(s) in
the pathogenesis of HCV. J. Med. Virol. 62:308-377, 2000. (C) 2000 Wiley-Li
ss, Inc.